Variant report
Variant | nsv967260 |
---|---|
Chromosome Location | chr3:95001173-95021114 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:95018524..95019390-chr9:5887461..5888104,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535471265 | chr3:95001201-95001202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530946743 | chr3:95001250-95001251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555876414 | chr3:95001280-95001281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546161230 | chr3:95001334-95001335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62269399 | chr3:95001360-95001361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12489010 | chr3:95001385-95001386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs538842085 | chr3:95007806-95007807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113421587 | chr3:95007830-95007831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7432472 | chr3:95007840-95007841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569431845 | chr3:95007905-95007906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538252119 | chr3:95007906-95007907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190518589 | chr3:95007914-95007915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139445044 | chr3:95007958-95007959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534245331 | chr3:95007975-95007976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144158894 | chr3:95007989-95007990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534853131 | chr3:95007997-95007998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74813265 | chr3:95008037-95008038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs544855294 | chr3:95008095-95008096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565220571 | chr3:95008098-95008099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180809254 | chr3:95008100-95008101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555039566 | chr3:95008126-95008127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544219906 | chr3:95008141-95008142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183961631 | chr3:95008158-95008159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377422866 | chr3:95008212-95008213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs188631608 | chr3:95008231-95008232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546333139 | chr3:95008254-95008255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181298482 | chr3:95008269-95008270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532772858 | chr3:95008297-95008298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72922642 | chr3:95008300-95008301 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs148612711 | chr3:95008325-95008326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185902560 | chr3:95008328-95008329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs16855681 | chr3:95008333-95008334 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs569576640 | chr3:95008340-95008341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190715058 | chr3:95008366-95008367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142039984 | chr3:95008384-95008385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181867370 | chr3:95008411-95008412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538843509 | chr3:95008435-95008436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75058659 | chr3:95008463-95008464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76234800 | chr3:95008486-95008487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544140282 | chr3:95008495-95008496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531418176 | chr3:95008517-95008518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187289394 | chr3:95008525-95008526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546385436 | chr3:95008552-95008553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139822341 | chr3:95008567-95008568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574120586 | chr3:95008579-95008580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539823646 | chr3:95008628-95008629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559829076 | chr3:95008632-95008633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs114051549 | chr3:95008639-95008640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192134290 | chr3:95008653-95008654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs151180797 | chr3:95008705-95008706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:94999600-95001400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr3:95007800-95008600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr3:95007800-95008800 | Enhancers | NH-A | brain |
4 | chr3:95007800-95009200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr3:95008800-95012200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:95009200-95020000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr3:95013000-95013200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr3:95013200-95014400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr3:95014400-95014600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr3:95014600-95015000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr3:95016600-95017000 | Enhancers | NH-A | brain |
12 | chr3:95017000-95020600 | Weak transcription | NH-A | brain |
13 | chr3:95017600-95018000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr3:95018400-95018600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr3:95019200-95020200 | Enhancers | Fetal Intestine Small | intestine |
16 | chr3:95020000-95021600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr3:95020200-95020800 | Weak transcription | Fetal Intestine Small | intestine |
18 | chr3:95020600-95021000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
19 | chr3:95020600-95021600 | Enhancers | NH-A | brain |
20 | chr3:95021000-95021200 | Enhancers | Fetal Intestine Small | intestine |